Unique therapy helps patient beat prostate cancer
Focal therapy, a treatment unique to the region and only offered at UC, helped Richard Weiss, 72, overcome prostate cancer with minimal side effects.
A diagnosis with prostate cancer was something Dick Weiss, 72, was not anticipating in May 2017, after his prostate-specific antigen (PSA) test came back higher than normal. After finding his way to a support group in Blue Ash for men with prostate cancer, he encountered experts from the University of Cincinnati Cancer Institute who were offering unique procedures, not offered elsewhere in the Tristate, to treat this type of cancer.
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.